Furthermore, we conducted in vivo treatment of TM00091 PDX tumours, which carry two BRCA1 point mutations (Q356R and C61G), with NOTCH1 hyperactivation (Supplementary Fig. 10a). The gene discussed is NOTCH1; the disease is neoplasm.